Drugs that contain Ranolazine

1. List of Aspruzyo Sprinkle drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10898444 SPIL Extended release multiparticulates of ranolazine
Jan, 2038

(14 years from now)

US11510878 SPIL NA
Jan, 2038

(14 years from now)

Market Authorisation Date: 28 February, 2022

Treatment: NA

Dosage: GRANULES, EXTENDED RELEASE;ORAL

More Information on Dosage

ASPRUZYO SPRINKLE family patents

2

United States

1

India

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic